Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 36x-70x upside based on similar BTD for BCG-unresponsive

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Mar 22, 2022 6:40pm

383 Views

Post# 34536061

RE:36x-70x upside based on similar BTD for BCG-unresponsive

If we are valued 70x more after breakthrough, our stock price would be $25.45. I would be very happy with that. Even at 30x our share price would be $10.90, again not bad. If this cancer treatment is as good as everyone is predicting, we could be much higher than these figures within a couple years, IMO

<< Previous

Bullboard Posts

Next >>

AI companies to invest in